Although tumours with either mutation in SETD2 or VHL, and both WT status did not change in size following TGX221 treatment (Fig. 6D), ACHN tumours were in general slightly larger than Caki-1 or 786O tumours (Fig. 6C). Here, VHL is linked to neoplasm.